With U.S. stocks booming, North American wealthy led the way globally. And the top 1% of wealthy globally—the so-called ...

Voyager struggles with a negative enterprise value, financial risks, and limited catalysts in a competitive Alzheimer's ...

Neuroscience technology company Brooklyn Health is using artificial intelligence to target a fundamental problem in neurology ...

Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration.

US drug companies are increasingly licensing experimental medicines invented by Chinese firms. The recent deals could be ...